Page last updated: 2024-11-07

cp 65,526

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azidoprazosin: labeled with 125I [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115344
MeSH IDM0123205

Synonyms (16)

Synonym
azidoprazosin
90990-97-9
(125i)iodoarylazidoprazosin
iodoazidoaryl prazosin
cp-65,526
cp 65,526
iodoaryl azidoprazosin
cp 65526
aryl azidoprazosin
2-(4-(4-azido-3-iodobenzoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
125i-iaap
piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(4-azido-3-iodobenzoyl)-
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(4-azido-3-iodophenyl)methanone
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(4-azido-3-iodobenzoyl)piperazine
(4-azido-3-iodophenyl)[4-(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)piperazin-1-yl]methanone
DTXSID90920021

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The human ATP-binding cassette transporter, ABCG2, confers resistance to multiple chemotherapeutic agents and also affects the bioavailability of different drugs."( The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
Ambudkar, SV; Bates, SE; Robey, RW; Shukla, S, 2006
)
0.33
" Based on studies in wild type and abcg2-/- mice, we observed that oral curcumin increased Cmax and relative bioavailability of sulfasalazine by selectively inhibiting ABCG2 function."( Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice.
Ambudkar, SV; Bauer, B; Hartz, A; Shukla, S; Ware, JA; Zaher, H, 2009
)
0.35
" However, the limited bioavailability of curcumin prevents its use for modulation of the function of these transporters in the clinical setting."( Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2.
Ambudkar, SV; Chufan, EE; Fukuda, M; Ishida, M; Iwabuchi, Y; Kanehara, K; Kudoh, K; Murakami, M; Naitoh, T; Ohnuma, S; Shibata, H; Sugisawa, N; Unno, M, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (9.52)18.7374
1990's27 (42.86)18.2507
2000's23 (36.51)29.6817
2010's7 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.64 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.54%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (98.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]